Product Information
NOVOLOG MIX 70-30 VIAL is a brand product labeled by Novo Nordisk, priced at $6.9287 per ML under NDC 00169368512. Its NADAC has been published 671 times since Nov 28, 2013.
Strength
100 [iU]/mL
Manufacturer
Novo NordiskNDC
00169368512
Classification
Brand
Dosage Form
INJECTION, SUSPENSION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
INSULIN ASPARTApproval Type
Biologic (BLA)
FDA Application
BLA021172On Market Since
11/1/2001
Pharmacological Classes
Price Statistics
The NADAC for NOVOLOG MIX 70-30 VIAL has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 55.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.9287 per ML |
|---|---|
| All-time high | $29.0089 (Jan 3, 2024) |
| All-time low | $6.9278 (Aug 19, 2026) |
| 52-week high | $6.9439 |
| 52-week low | $6.9278 |
| Median price | $27.4596 |
| Average price | $22.1864 |
| Largest weekly change | -75.9% (Jan 10, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Novo Nordisk manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
insulin aspart market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Insulin Analog class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NOVOLOG MIX 70-30 VIAL?
The current National Average Drug Acquisition Cost (NADAC) for NOVOLOG MIX 70-30 VIAL, manufactured by Novo Nordisk, is $6.9287 per ML (NDC 00169368512), effective Sep 30, 2026.
How has the price of NOVOLOG MIX 70-30 VIAL changed over time?
Over the history we have for it, the NADAC for NOVOLOG MIX 70-30 VIAL has declined 55.7%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NOVOLOG MIX 70-30 VIAL?
Since Nov 28, 2013, the NADAC for NOVOLOG MIX 70-30 VIAL has ranged from a low of $6.9278 (Aug 19, 2026) to a high of $29.0089 (Jan 3, 2024), with a median of $27.4596 per ML.
Are there cheaper alternatives to NOVOLOG MIX 70-30 VIAL?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as NOVOLOG MIX 70-30 VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures NOVOLOG MIX 70-30 VIAL?
NOVOLOG MIX 70-30 VIAL (NDC 00169368512) is labeled by Novo Nordisk, and CMS classifies it as a brand product.